← FDA Drug Approvals (Drugs@FDA)
PIPERACILLIN AND TAZOBACTAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASTRAL · Approved 2019-07-29
Drug application
- FDA Application #
ANDA212287- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PIPERACILLIN AND TAZOBACTAM
- Generic name
- Piperacillin Sodium
- Active ingredients
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- ASTRAL
- First approval
- 2019-07-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown